Esperion Therapeutics
ESPR
#6587
Rank
C$1.15 B
Marketcap
C$4.48
Share price
0.00%
Change (1 day)
116.64%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of March 2026 : C$0.65 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are C$0.65 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$0.63 B29.32%
2024-12-31C$0.49 B80.75%
2023-12-31C$0.27 B-18.87%
2022-12-31C$0.33 B-30.82%
2021-12-31C$0.48 B7.97%
2020-12-31C$0.45 B60.82%
2019-12-31C$0.28 B43.33%
2018-12-31C$0.19 B-44.06%
2017-12-31C$0.34 B6%
2016-12-31C$0.32 B-19.63%
2015-12-31C$0.41 B146.6%
2014-12-31C$0.16 B99.5%
2013-12-31C$83.34 M1046.17%
2012-12-31C$7.27 M227.95%
2011-12-31C$2.21 M
2002-12-31C$81.19 M-34.94%
2001-12-31C$0.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
C$292.57 B 44,787.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$57.59 B 8,735.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$1.82 B 180.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C$0.37 B-41.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$1.33 B 105.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$12.10 B 1,757.40%๐Ÿ‡บ๐Ÿ‡ธ USA